Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.

Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.

DNA microarrays represent the largest segment of this market and will continue to be the largest contributor during the study period (2010-2015). However, this segment will be closely followed by lab-on-chip (LOC) in the coming years due to its wide applications and increased adoption by various biotechnology, pharmaceutical companies, and research laboratories.

1.
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays)Trends & Global Forecast (2010-2015)Published: August 2011No. of Pages: 278Price: $ 4650A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on asolid platform that allows multiple tests to be performed at the same time with increasedefficiency and higher speed. The global biochip market is studied by the types and keyapplications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications incancer diagnostics and expression profiling, the boom in personalized medicine, andgovernment funding.DNA microarrays represent the largest segment of this market and will continue to be thelargest contributor during the study period (2010-2015). However, this segment will beclosely followed by lab-on-chip (LOC) in the coming years due to its wide applications andincreased adoption by various biotechnology, pharmaceutical companies, and researchlaboratories. The third largest segment – protein microarrays will be the fastest growingsegment; forecasted to grow at a CAGR of 19.9% during the study period due to advancesin the fields of genomics and proteomics and improvements in the field of recombinantproteins.Reverse phase protein microarrays designed for targeted therapies in cancer holds promisein the global biochips market in the next 5-10 years. These microarrays provide increasedaccuracy and enhanced efficacy for the detection of rare molecules as compared to existingmicroarray surfaces for cancer research & diagnosis to help understand the proteins intumor cells. Thus, they have helped open the avenues for personalized methods for cancertherapy.The market of Asia will account for a bulk of the future biochip market growth due to itshigh growth potential and huge demand from emerging economies such as India and China- the large pool of heterogeneous patient population, and increasing R&D investment inthese countries. The top players in the biochip market such as Affymetrix, Inc., Illumina,Inc., and Fluidigm Corporation have relocated their manufacturing base to Singapore to takeadvantage of the benefits the country offers; coupled with rising demand from neighboringcountries of Asia. The players also benefit from a well-established semiconductor

2.
manufacturing base including chip technologies. Singapore has made focused efforts toattract life sciences corporates with dedicated investments accounting for 3% of thecountrys GDP. It came up with its R&D center - Singapores Biopolis R&D center in 2003-2004 and is home to the Genome Institute of Singapore.Scope of the reportThis research report categorizes the global biochips market on the basis of applications,types, and geography; forecasting revenues and analyzing trends in each of the followingsubmarkets:On the basis of applications:DNA applications: Gene expression, SNP genotyping, cancer diagnosis & treatment,genomics, agricultural biotechnology, drug discovery, and others.Lab on chip applications: Drug discovery, genomics, diagnostics, proteomics, IVD & POC,high throughput screening, and others.Protein microarray applications: Expression profiling, proteomics, high throughputscreening, diagnostics, drug discovery, and others.Other array applications: Expression profiling, cancer diagnostics, toxicogenomics,genomics, drug discovery, and others.On the basis of types:DNA microarrays, lab on chip, protein microarrays, other arrays (cell arrays and tissuearrays)On the basis of geography:North America, Europe, Asia, and Rest of the World.Each section will provide market data, market drivers, trends and opportunities, top-sellingproducts, key players, and competitive outlook. It will also provide market tables forcovering the sub-segments. In addition, the report will throw light on more than 20company profiles covering all the sub-segments.TABLE OF CONTENTS1 INTRODUCTION1.1 KEY TAKE-AWAYS1.2 REPORT DESCRIPTION1.3 MARKETS COVERED1.4 STAKEHOLDERS1.5 RESEARCH METHODOLOGY1.5.1 MARKET SIZE1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES